COLL vs WAT · P/E 17, rev $181.9M vs P/E 32, rev $1.65B
Collegium Pharmaceutical Inc (COLL) versus Waters Corporation (WAT) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Waters Corporation (WAT) is a diagnostics & research company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported WAT revenue for 2026-07-04 was $1.65B. Net income was -$136.0M. Revenue was up 29.8% from 2026-04-04 to 2026-07-04. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
Not investment advice. Open the COLL and WAT stock pages for the full models.
Not investment advice.